No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
939 |
4. Check minimum number of eventsNone |
939 |
5. Include endpointsNone |
939 |
6. Filter based on genotype QC (FinnGen only) |
939 |
Control definitions (FinnGen only)
- Control exclude
- F5_SCHIZO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F20-F29
- Name in latin
- Perturbatio schizotypica
Similar endpoints
↥List of similar endpoints to
Schizotypal disorder
based on the number of shared cases.
Similar with more cases:
- Schizophrenia or delusion
- Schizophrenia or delusion, excluding more controls
- Schizophrenia, schizotypal and delusional disorders
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7086 | 3051 | 4005 |
| Only index persons | 6600 | 2891 | 3709 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.09 | 0.11 |
| Only index persons | 0.13 | 0.11 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 36.34 | 39.46 | 33.89 |
| Only index persons | 35.74 | 38.80 | 33.36 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 939 | 484 | 455 |
| Unadjusted period prevalence (%) | 0.18 | 0.16 | 0.20 |
| Median age at first event (years) | 34.81 | 35.31 | 34.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 899
- Matched controls
- 8989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N05AB03
ATC
perphenazine; systemic, rectal
125.2
323.0
338
43
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
616.7
323.0
795
110
F21
ICD-10 Finland
Schizotypal disorder
+∞
323.0
899
*
N05AX12
ATC
aripiprazole; systemic
78.0
323.0
384
85
N05AX08
ATC
risperidone; systemic
141.9
323.0
570
108
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1796.9
323.0
452
5
N05AH03
ATC
olanzapine; systemic
100.5
323.0
540
132
N05AH04
ATC
quetiapine; oral
19.3
320.0
592
817
F20.9
ICD-10 Finland
Schizophrenia, unspecified
+∞
298.0
269
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3030.3
261.6
240
*
N05AH02
ATC
clozapine; systemic
1631.0
259.5
240
*
N05AA02
ATC
levomepromazine; systemic
63.3
246.1
284
65
N05AF03
ATC
chlorprothixene; systemic
79.6
223.9
249
43
P72
ICPC
Schizophrenia
2666.2
209.8
195
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
+∞
196.2
181
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
177.1
164
*
N03AG01
ATC
valproic acid; systemic, rectal
19.9
168.4
266
186
N05BA06
ATC
lorazepam; systemic, sublingual
31.1
161.8
219
92
N04AA02
ATC
biperiden; systemic
133.4
156.2
164
15
N06AB04
ATC
citalopram; systemic
7.6
150.2
445
1029
188
Kela drug reimbursment
Psychosis requiring demanding treatment
+∞
149.2
139
*
N05BA01
ATC
diazepam; systemic, rectal
9.6
136.8
315
477
N05AD01
ATC
haloperidol; systemic
55.4
135.1
160
35
N05CD07
ATC
temazepam; oral
11.3
122.0
249
295
N05AC02
ATC
thioridazine; oral
60.9
115.9
135
26
P99
ICPC
Psychological disorders other
24.5
113.6
164
81
N05BA04
ATC
oxazepam; oral
5.8
112.5
409
1134
T36
ICD-10 Finland
Poisoning by systemic antibiotics
13.8
111.2
202
185
N05AA01
ATC
chlorpromazine; systemic, rectal
161.2
108.9
113
8
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
+∞
108.6
102
*
F22.0
ICD-10 Finland
Delusional disorder
590.5
108.2
105
*
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
+∞
105.3
99
*
P29
ICPC
Psychological sympt/compl other
11.0
104.4
213
246
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
+∞
99.9
94
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
28.7
98.3
135
55
N06AB03
ATC
fluoxetine; oral
7.0
97.6
276
537
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.3
97.4
301
660
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
14.2
95.1
169
144
F61.0
ICD-10 Finland
Mixed personality disorders
26.2
94.4
133
59
N05AF05
ATC
zuclopenthixol; systemic
343.7
92.7
92
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.1
91.4
252
468
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
+∞
88.0
83
*
N03AX09
ATC
lamotrigine; oral
11.3
87.1
173
185
N06AX16
ATC
venlafaxine; oral
5.6
86.6
296
720
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
+∞
85.8
81
*
N06AB06
ATC
sertraline; oral
6.3
85.3
257
533
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
28.2
84.2
116
47
F20
ICD-10 Finland
Schizophrenia
+∞
82.6
78
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
23.1
81.4
119
59
N05BE01
ATC
buspirone; oral
17.7
80.4
129
84
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
827.1
78.6
76
*
N05AE04
ATC
ziprasidone; systemic
172.9
76.4
79
5
N05AN01
ATC
lithium; oral
22.6
73.5
108
54
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
17.8
73.1
117
75
N05CF01
ATC
zopiclone; oral
4.0
71.6
381
1399
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
27.4
70.7
98
40
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
20.6
70.0
106
58
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
7.3
68.0
177
292
N03AE01
ATC
clonazepam; systemic
9.7
67.9
145
174
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.8
66.7
212
455
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.0
65.6
176
302
F20.0
ICD-10 Finland
Paranoid schizophrenia
+∞
65.4
62
*
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
+∞
65.4
62
*
N06AB05
ATC
paroxetine; oral
7.3
65.2
169
276
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
+∞
64.3
61
*
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
13.0
64.2
117
102
P98
ICPC
Psychosis NOS/other
144.5
63.8
67
5
F60.9
ICD-10 Finland
Personality disorder, unspecified
20.0
63.5
97
54
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
39.2
62.5
79
22
N06AX11
ATC
mirtazapine; oral
3.4
61.2
407
1740
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
33.6
61.1
80
26
F99
ICD-10 Finland
Mental disorder, not otherwise specified
16.5
59.8
98
66
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
8.6
59.2
136
183
N05AL01
ATC
sulpiride; systemic
38.3
58.3
74
21
IGY02
NOMESCO Finland
Psychiatric monitoring contact
18.3
57.8
91
55
SPAT1240
SPAT
Therapeutic discussion
4.8
57.7
219
566
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
12.0
53.5
101
94
N05AX13
ATC
paliperidone; systemic
548.8
53.1
52
*
SPAT1234
SPAT
Support of social functional capacity
11.5
52.4
101
98
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
14.6
51.9
89
67
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
+∞
50.5
48
*
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
183.7
50.4
52
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
17.7
49.2
78
48
N07BB01
ATC
disulfiram; oral
6.6
49.1
134
231
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.9
48.5
177
432
F60.1
ICD-10 Finland
Schizoid personality disorder
105.8
46.3
50
5
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.7
45.9
174
440
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
3.5
45.8
254
903
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
12.1
45.5
85
77
F20.5
ICD-10 Finland
Residual schizophrenia
+∞
45.2
43
*
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
+∞
45.2
43
*
C07AA05
ATC
propranolol; systemic
3.4
45.1
270
1016
EBA00
NOMESCO Finland
Extraction of tooth
2.9
45.0
401
1978
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
34.3
44.7
58
18
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
459.4
44.6
44
*
N05AF01
ATC
flupentixol; systemic
20.3
43.8
66
35
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
+∞
43.1
41
*
N06AX03
ATC
mianserin; oral
7.8
42.2
101
143
F28
ICD-10 Finland
Other nonorganic psychotic disorders
+∞
42.0
40
*
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
+∞
42.0
40
*
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
+∞
40.9
39
*
N05BA12
ATC
alprazolam; oral
4.3
40.1
163
438
IGY99
NOMESCO Finland
Other psychiatric treatment contact
16.3
39.3
64
42
3012C
ICD-9 Finland
Personality disorders, Schizoid personality disorder[PSYKOOSIPIIRTEINEN PERSOONALLISUUS]
+∞
38.8
37
*
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
393.3
38.3
38
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.6
38.2
144
358
F10.20
ICD-10 Finland
Alcohol dependence currently independent
11.3
38.0
73
70
A06AD11
ATC
lactulose; oral
4.7
37.6
138
333
OAB43
SPAT
NA
0.1
37.3
22
1437
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
22.4
36.5
53
25
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
34.5
35.7
46
14
F20.8
ICD-10 Finland
Other schizophrenia
+∞
35.7
34
*
F20.10
ICD-10 Finland
Raise schizophrenia continuously
+∞
35.7
34
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.0
35.4
122
275
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
20.0
35.2
53
28
N05AE03
ATC
sertindole; oral
360.6
35.2
35
*
T90
ICPC
Diabetes non-insulin dependent
3.2
34.6
207
758
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.9
34.3
158
471
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
43.9
34.3
42
10
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
14.0
34.1
59
45
IGV01
NOMESCO Finland
Psychiatric network contact
33.0
33.8
44
14
F25
ICD-10 Finland
Schizoaffective disorders
+∞
33.5
32
*
P28
ICPC
Limited function/disability (P)
26.8
33.5
46
18
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
26.8
33.5
46
18
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
10.1
33.1
67
71
A10BA02
ATC
metformin; oral
2.9
32.7
235
972
P01
ICPC
Feeling anxious/nervous/tense
3.4
32.7
176
593
F41.1
ICD-10 Finland
Generalized anxiety disorder
5.3
32.5
104
215
F61
ICD-10 Finland
Mixed and other personality disorders
33.8
32.5
42
13
N06AA04
ATC
clomipramine; systemic
15.6
32.2
53
36
N06AA12
ATC
doxepin; systemic
6.5
32.0
86
143
N06AG02
ATC
moclobemide; oral
6.7
31.9
84
136
M01AH05
ATC
etoricoxib; oral
0.4
31.9
234
4156
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
38.0
31.7
40
11
N06AB10
ATC
escitalopram; oral
2.7
31.6
267
1216
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
+∞
31.4
30
*
29580
ICD-8 Finland
Schizophrenia, Other
+∞
31.4
30
*
N06AX12
ATC
bupropion; oral
4.3
31.4
126
330
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.5
31.4
162
528
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
18.0
30.9
48
28
L17
ICPC
Foot/toe symptom/complaint
2.7
30.7
250
1111
F60.0
ICD-10 Finland
Paranoid personality disorder
39.6
30.5
38
10
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
+∞
30.4
29
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.5
30.3
94
187
P76
ICPC
Depressive disorder
4.3
30.1
120
312
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.1
30.0
184
680
SPAT1254
SPAT
Administration of medicine
3.5
29.9
154
500
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
36.0
29.8
38
11
N05BA02
ATC
chlordiazepoxide; systemic
10.1
29.8
60
63
N06AB08
ATC
fluvoxamine; oral
9.2
29.6
63
73
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
+∞
29.3
28
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
+∞
29.3
28
*
P73
ICPC
Affective psychosis
41.6
29.2
36
9
F34.1
ICD-10 Finland
Dysthymia
6.0
28.8
82
147
SPAT1249
SPAT
Treatment-related counselling outside office
2.3
28.6
383
2201
K02.1
ICD-10 Finland
Caries of dentine
2.2
28.4
611
4364
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
+∞
28.3
27
*
J01FA10
ATC
azithromycin; systemic
0.4
28.1
265
4373
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
80.3
27.9
31
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
44.0
27.9
34
8
IEY01
NOMESCO Finland
Psychoeducation, individual
26.4
27.7
38
15
P74
ICPC
Anxiety disorder/anxiety state
5.5
27.4
84
165
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
+∞
27.2
26
*
SPAT1243
SPAT
Psychiatric/psychological examination
7.0
27.2
69
106
A28
ICPC
Limited function/disability NOS
4.1
27.0
112
301
F39
ICD-10 Finland
Unspecified mood [affective] disorder
8.9
26.9
58
69
P27
ICPC
Fear of mental disorder
15.4
26.7
44
30
N05AD03
ATC
melperone; systemic
22.0
26.3
38
18
F20.6
ICD-10 Finland
Simple schizophrenia
+∞
26.2
25
*
F60.8
ICD-10 Finland
Other specific personality disorders
17.1
26.0
41
25
RS220
NOMESCO Finland
NA
17.1
26.0
41
25
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
34.2
25.7
33
10
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
9.5
25.5
53
59
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
25.1
267
1353
29999
ICD-8 Finland
Unspecified psychosis
+∞
25.1
24
*
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
+∞
25.1
24
*
F40.1
ICD-10 Finland
Social phobias
6.6
25.0
66
107
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
25.0
286
1501
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
22.0
24.9
36
17
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
22.0
24.9
36
17
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
3.2
24.6
143
504
A04
ICPC
Weakness/tiredness general
3.2
24.6
139
481
SPAT1301
SPAT
No procedures
2.3
24.4
292
1563
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
+∞
24.1
23
*
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
+∞
24.1
23
*
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
9.4
24.0
50
56
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
12.1
23.7
43
37
AA400
NOMESCO Finland
Electroconvulsive therapy
20.2
23.6
35
18
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
3.4
23.5
123
401
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.5
23.5
117
367
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
10.7
23.3
45
44
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
23.3
220
1041
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
8.3
23.3
52
66
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.5
23.2
51
63
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
19.1
23.2
35
19
B18.2
ICD-10 Finland
Chronic viral hepatitis C
12.2
23.2
42
36
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
20.7
23.1
34
17
S29
ICPC
Skin symptom/complaint other
2.8
23.1
161
639
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
+∞
23.0
22
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.5
22.9
214
1006
Z03
ICPC
Housing/neighbourhood problem
41.3
22.8
28
7
P50
ICPC
Psychological, Medication/prescr/renewal
235.7
22.7
23
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.6
22.5
80
185
SPAT1310
SPAT
Counselling related to known health issue
2.2
22.4
290
1598
F31.8
ICD-10 Finland
Other bipolar affective disorders
7.9
22.1
51
68
WX290
NOMESCO Finland
Other blockade of nerve
2.0
22.1
496
3424
M03BX02
ATC
tizanidine; oral
0.5
22.1
314
4676
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
+∞
22.0
21
*
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
+∞
22.0
21
*
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
14.2
21.9
37
27
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
25.8
21.9
30
12
SPAT1307
SPAT
Psychosocial counselling and guidance
3.7
21.6
101
301
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
21.4
685
5412
IGY02
SPAT
NA
23.8
21.4
30
13
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
21.2
529
3776
P80
ICPC
Personality disorder
34.7
21.2
27
8
H13
ICPC
Plugged feeling ear
2.9
21.1
144
562
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
13.8
21.1
36
27
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.4
21.1
218
1076
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
+∞
20.9
20
*
P15
ICPC
Chronic alcohol abuse
5.9
20.9
59
105
A05
ICPC
Feeling ill
4.2
20.8
82
210
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
214.7
20.7
21
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
30.9
20.6
27
9
U04
ICPC
Incontinence urine
8.2
20.5
46
59
T82
ICPC
Obesity
5.3
20.4
64
129
SPAT1260
SPAT
Consultation of another employee
2.6
20.4
167
726
F60.2
ICD-10 Finland
Dissocial personality disorder
33.4
20.3
26
8
R53
ICD-10 Finland
Malaise and fatigue
2.4
20.1
196
934
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
24.0
20.0
28
12
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.7
20.0
93
275
K59.09
ICD-10 Finland
Constipation, unspecified
5.0
20.0
65
137
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
36.7
19.9
25
7
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.6
19.8
59
112
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
8.0
19.8
45
59
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
4.4
19.7
73
176
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.3
19.7
49
1424
-1
NOMESCO Finland
NA
2.0
19.6
342
2109
F05.9
ICD-10 Finland
Delirium, unspecified
15.0
19.5
32
22
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
16.0
19.4
31
20
IEV99
NOMESCO Finland
Other psychiatric network intervention
32.1
19.3
25
8
D12
ICPC
Constipation
6.8
19.3
49
76
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
19.3
385
2497
Z72.8
ICD-10 Finland
Other problems related to lifestyle
23.1
19.1
27
12
WX110
NOMESCO Finland
Local anesthesy
2.0
19.1
651
5122
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
18.9
531
3886
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
18.9
479
3380
SPAT1241
SPAT
Extensive assessment of psychosocial situation
11.3
18.8
35
32
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
8.9
18.8
40
47
F20.03
ICD-10 Finland
Paranoid schizophrenia periodically with gradual improvement
+∞
18.8
18
*
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
17.6
18.8
29
17
KMAK
NOMESCO Finland
NA
1.9
18.3
529
3888
IER01
NOMESCO Finland
Psychoeducation, group
18.0
18.3
28
16
H81
ICPC
Excessive ear wax
2.9
18.3
122
468
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.8
18.3
42
56
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.3
18.3
58
1512
SAA02
NOMESCO Finland
Basic examination of mouth
1.9
18.2
620
4825
S10
ICPC
Boil/carbuncle
4.1
18.1
73
191
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
53.7
18.0
21
*
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
7.3
18.0
43
61
N06AA09
ATC
amitriptyline; systemic
3.2
17.9
100
339
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
+∞
17.8
17
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
12.8
17.7
31
25
F41.8
ICD-10 Finland
Other specified anxiety disorders
5.6
17.6
52
98
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
29.4
17.5
23
8
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
17.4
17.5
27
16
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
19.1
17.4
26
14
N03AF01
ATC
carbamazepine; oral, rectal
4.4
17.2
63
151
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
51.0
17.0
20
*
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
13.6
17.0
29
22
P18
ICPC
Medication abuse
22.4
16.9
24
11
N05AB01
ATC
dixyrazine; systemic
12.4
16.9
30
25
R41.0
ICD-10 Finland
Disorientation, unspecified
10.0
16.8
33
34
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
+∞
16.7
16
*
F20.38
ICD-10 Finland
Undifferentiated schizophrenia other definite
+∞
16.7
16
*
F25.81
ICD-10 Finland
Other specified schizoaffective disorder with prolonged schizophrenic than bipolar symptoms
+∞
16.7
16
*
N06AX05
ATC
trazodone; oral
5.7
16.7
48
88
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
16.7
94
322
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
28.1
16.6
22
8
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
28.1
16.6
22
8
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
16.6
170
825
SPAT1252
SPAT
Overall medication plan or its review
4.2
16.5
63
157
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
20.5
16.5
24
12
P19
ICPC
Drug abuse
9.5
16.3
33
36
F84.5
ICD-10 Finland
Asperger syndrome
17.1
16.1
25
15
N05AE05
ATC
lurasidone; oral
25.0
16.1
22
9
AA1AD
NOMESCO Finland
CT of head and brain
2.2
16.0
175
874
N05CD02
ATC
nitrazepam; oral
14.8
15.9
26
18
SPAT1312
SPAT
General health counselling
1.9
15.9
289
1781
30188
ICD-8 Finland
Personality disorders, Alia definita
61.1
15.8
18
*
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
16.0
15.8
25
16
29599
ICD-8 Finland
Schizophrenia, Unspecified type
+∞
15.7
15
*
F23.20
ICD-10 Finland
Acute schizophrenia-like psychosis without acute stress factor
+∞
15.7
15
*
30041
ICD-8 Finland
Neuroses, Depressiva
26.8
15.6
21
8
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.6
15.4
71
209
K08.3
ICD-10 Finland
Retained dental root
3.1
15.4
86
292
S06
ICPC
Rash localized
4.3
15.2
57
140
N05AC01
ATC
periciazine; systemic
23.8
15.2
21
9
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
20.5
15.1
22
11
K59.0
ICD-10 Finland
Constipation
4.2
15.1
57
141
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
9.1
15.0
31
35
V03AA01
ATC
NA
7.2
15.0
36
52
F10.24
ICD-10 Finland
Alcohol depence active use
7.2
15.0
36
52
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.6
15.0
115
477
OAA65
SPAT
NA
0.2
14.9
14
699
Z00.0
ICD-10 Finland
General medical examination
2.2
14.9
166
834
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
57.7
14.8
17
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
14.7
100
385
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
21.5
14.7
21
10
N06AA06
ATC
trimipramine; systemic
5.7
14.7
42
77
J01FA09
ATC
clarithromycin; systemic
0.5
14.6
99
1938
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
+∞
14.6
14
*
F23.10
ICD-10 Finland
Acute polymorphic psychosis with schizophrenic disease picture without acute stress factor
+∞
14.6
14
*
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
+∞
14.6
14
*
F20.19
ICD-10 Finland
Hebefren schizophrenia UNS
+∞
14.6
14
*
2971A
ICD-9 Finland
Paranoid states, Paranoia
+∞
14.6
14
*
A29
ICPC
General symptom/complaint other
2.8
14.5
99
381
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.6
14.4
66
194
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
17.3
14.3
22
13
R11
ICD-10 Finland
Nausea and vomiting
3.1
14.3
83
290
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
22.7
14.3
20
9
G04BD04
ATC
oxybutynin; oral, transdermal
4.8
14.2
47
102
SPAT1263
SPAT
Sampling
1.8
14.1
358
2446
SPAT1262
SPAT
Handing over of treatment supplies
2.2
14.1
148
724
OAB48
SPAT
NA
0.2
14.0
13
653
R02
ICPC
Shortness of breath/dyspnoea
2.7
14.0
103
417
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
16.1
14.0
22
14
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
30.6
13.9
18
6
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.5
13.9
41
78
30088
ICD-8 Finland
Neuroses, Other
54.2
13.8
16
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
13.8
13.8
23
17
OAA67
SPAT
NA
0.1
13.7
6
500
F20.4
ICD-10 Finland
Post-schizophrenic depression
+∞
13.6
13
*
F32.8
ICD-10 Finland
Other depressive episodes
6.9
13.5
33
49
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.2
13.4
32
46
S21
ICPC
Skin texture symptom/complaint
2.5
13.4
107
455
F41.00
ICD-10 Finland
Moderate panic disorder
5.9
13.4
37
65
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
13.4
60
173
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
13.4
253
1561
F10.09
ICD-10 Finland
Alcohol intoxication UNS
5.2
13.3
41
82
EBA30
NOMESCO Finland
Excision of root of tooth
3.3
13.2
67
213
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
40.7
13.2
16
*
C07AB07
ATC
bisoprolol; oral
1.8
13.2
293
1906
SPAT1244
SPAT
Occupational therapy
15.3
13.1
21
14
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.8
13.1
43
93
-50
ICPC
Medication/prescr/renewal
4.2
13.0
49
121
N05BA05
ATC
potassium clorazepate; oral
17.0
13.0
20
12
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
28.8
13.0
17
6
IHZ07
SPAT
NA
28.8
13.0
17
6
IGP01
NOMESCO Finland
Psychiatric family contact
28.8
13.0
17
6
30180
ICD-8 Finland
Personality disorders, Immatura
22.9
12.9
18
8
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
50.8
12.9
15
*
F51.0
ICD-10 Finland
Nonorganic insomnia
2.2
12.8
142
710
SPAT1097
SPAT
Recording of ECG
2.4
12.8
109
480
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
12.8
547
4309
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.6
12.8
44
100
L15
ICPC
Knee symptom/complaint
2.1
12.7
159
835
A27
ICPC
Fear of other disease NOS
4.5
12.7
45
105
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
15.7
12.7
20
13
F93.89
ICD-10 Finland
Other childhood emotional disorders
15.7
12.7
20
13
RS140
NOMESCO Finland
NA
70.9
12.6
14
*
RT150
NOMESCO Finland
NA
70.9
12.6
14
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.4
12.6
59
1331
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
12.6
277
1795
R5599
NOMESCO Finland
Other rehabilitation service
5.2
12.6
38
75
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
17.6
12.5
19
11
S22
ICPC
Nail symptom/complaint
3.8
12.5
53
146
F20.33
ICD-10 Finland
Undifferentiated schizophrenia periodically with gradual improvement
+∞
12.5
12
*
F20.20
ICD-10 Finland
Catatonic schizophrenia continuously
+∞
12.5
12
*
29540
ICD-8 Finland
Acute schizophrenia episode
+∞
12.5
12
*
N17
ICPC
Vertigo/dizziness
2.7
12.5
85
329
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
12.5
85
330
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
131.7
12.5
13
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.3
12.5
62
195
N06AX18
ATC
reboxetine; oral
9.1
12.3
25
28
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
38.1
12.2
15
*
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
16.1
12.2
19
12
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.9
12.1
50
135
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
18.3
12.1
18
10
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
27.1
12.1
16
6
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.9
12.1
39
83
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
21.6
12.0
17
8
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.7
12.0
27
36
P16
ICPC
Acute alcohol abuse
6.3
11.9
31
51
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.3
11.7
58
182
A99
ICPC
Disease/condition unspecnature/site
2.9
11.7
71
255
F30.9
ICD-10 Finland
Manic episode, unspecified
30.5
11.7
15
5
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
11.7
319
2195
D01
ICPC
Abdominal pain/cramps general
2.4
11.7
106
481
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.3
11.6
25
792
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
65.8
11.6
13
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
8.3
11.6
25
31
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
23.2
11.6
16
7
M01AB05
ATC
diclofenac; systemic, rectal
0.6
11.6
369
4788
P03
ICPC
Feeling depressed
2.3
11.5
110
509
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
11.5
108
498
K04.1
ICD-10 Finland
Necrosis of pulp
2.2
11.5
117
561
R06AX27
ATC
desloratadine; oral
0.5
11.5
99
1806
RT250
NOMESCO Finland
NA
121.5
11.4
12
*
R44.0
ICD-10 Finland
Auditory hallucinations
121.5
11.4
12
*
Z08
ICPC
Social welfare problem
7.4
11.3
26
36
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
35.5
11.3
14
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
35.5
11.3
14
*
R06.0
ICD-10 Finland
Dyspnoea
1.9
11.3
172
974
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.7
11.2
37
81
OAB95
SPAT
NA
0.1
11.2
*
364
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
12.9
11.2
19
15
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
12.9
11.2
19
15
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.8
11.1
70
259
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.1
11.1
42
105
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
43.9
10.9
13
*
IFC99
NOMESCO Finland
Other biological psychiatric intervention
43.9
10.9
13
*
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.4
10.9
58
1251
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
10.9
148
805
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
28.4
10.7
14
5
C10AA01
ATC
simvastatin; oral
1.8
10.7
216
1349
Z72.2
ICD-10 Finland
Drug use
13.1
10.7
18
14
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
13.1
10.7
18
14
P20
ICPC
Memory disturbance
3.3
10.6
52
162
R42
ICD-10 Finland
Dizziness and giddiness
2.0
10.6
146
795
Z00.8
ICD-10 Finland
Other general examinations
2.7
10.6
73
283
-45
ICPC
Observ/health educat/advice/diet
4.4
10.6
37
86
F33.8
ICD-10 Finland
Other recurrent depressive disorders
8.6
10.6
22
26
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.8
10.5
228
1453
A69
ICPC
General and Unspecified, Other reason for encounter NEC
5.5
10.5
30
56
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.5
10.4
80
333
F12.21
ICD-10 Finland
Dependence caused by cannabis currently independent but staying in a controlling environment
111.3
10.4
11
*
F10.50
ICD-10 Finland
Alcohol-related psychosis is schizophrenic
111.3
10.4
11
*
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
111.3
10.4
11
*
F20.31
ICD-10 Finland
Undifferentiated schizophrenia periodically with gradual deterioration
+∞
10.4
10
*
F22.8
ICD-10 Finland
Other persistent delusional disorders
+∞
10.4
10
*
R01AD12
ATC
fluticasone furoate; nasal
0.5
10.4
120
2018
F50.9
ICD-10 Finland
Eating disorder, unspecified
7.8
10.4
23
30
J01AA02
ATC
doxycycline; systemic
0.6
10.4
452
5548
Z29
ICPC
Social problem NOS
5.2
10.4
31
61
P06
ICPC
Sleep disturbance
2.3
10.4
96
441
N05AH05
ATC
asenapine; oral
32.9
10.3
13
*
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.1
10.3
128
668
E66.8
ICD-10 Finland
Other obesity
3.1
10.3
56
189
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
0.6
10.3
199
2925
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.2
10.2
13
546
L28
ICPC
Limited function/disability (L)
2.3
10.1
94
431
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
10.1
352
2560
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
11.5
10.1
18
16
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.6
10.1
25
39
R35
ICD-10 Finland
Polyuria
3.1
10.0
54
181
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
40.5
10.0
12
*
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
40.5
10.0
12
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.0
9.9
38
97
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.0
9.9
56
192
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
16.9
9.9
15
9
IHZ04
SPAT
NA
12.3
9.9
17
14
L04
ICPC
Chest symptom/complaint
3.0
9.9
56
193
OAA80
SPAT
NA
0.1
9.9
6
397
R01AD09
ATC
mometasone; nasal
0.6
9.8
220
3137
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
26.3
9.8
13
5
N03AX11
ATC
topiramate; oral
4.1
9.8
37
93
SPAT1227
SPAT
Substance abuse rehabilitation
9.7
9.8
19
20
R32
ICD-10 Finland
Unspecified urinary incontinence
6.6
9.8
24
37
SPAT1104
SPAT
Monitoring of emergency patient
3.0
9.7
55
189
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
13.5
9.7
16
12
R01BA52
ATC
pseudoephedrine, combinations; oral
0.5
9.7
106
1815
R44.3
ICD-10 Finland
Hallucinations, unspecified
55.6
9.7
11
*
ICB03
SPAT
NA
55.6
9.7
11
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
55.6
9.7
11
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
55.6
9.7
11
*
F30.0
ICD-10 Finland
Hypomania
55.6
9.7
11
*
E66
ICD-10 Finland
Obesity
3.2
9.6
49
159
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
10.2
9.5
18
18
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.7
9.5
41
116
F19.50
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic
101.0
9.4
10
*
F12.5
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, psychotic disorder
101.0
9.4
10
*
F12.20
ICD-10 Finland
Dependence caused by cannabis currently independent
101.0
9.4
10
*
N05AB02
ATC
fluphenazine; systemic
17.7
9.4
14
8
29530
ICD-8 Finland
Schizophrenia, Paranoid type
+∞
9.4
9
*
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
+∞
9.4
9
*
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
+∞
9.4
9
*
WVA20
SPAT
NA
12.5
9.4
16
13
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
21.9
9.4
13
6
I95.1
ICD-10 Finland
Orthostatic hypotension
7.0
9.4
22
32
Z02.7
ICD-10 Finland
Issue of medical certificate
2.7
9.3
62
237
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
10.8
9.3
17
16
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
9.3
682
7581
D82
ICPC
Teeth/gum disease
1.6
9.3
323
2339
S04
ICPC
Lump/swelling localized
2.3
9.3
83
374
Z01.2
ICD-10 Finland
Dental examination
1.6
9.2
356
2643
D09
ICPC
Nausea
3.2
9.2
48
158
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.5
9.2
71
295
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.4
9.0
32
814
Z04.6
ICD-10 Finland
General psychiatric examination, requested by authority
37.1
9.0
11
*
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
37.1
9.0
11
*
L14
ICPC
Leg/thigh symptom/complaint
2.7
9.0
60
229
S97
ICPC
Chronic ulcer skin
3.9
9.0
36
96
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
9.0
23
669
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
18.8
8.9
13
7
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
5.6
8.9
25
46
S72.0
ICD-10 Finland
Fracture of neck of femur
6.9
8.9
21
31
SPAT1251
SPAT
Organisation of medication
4.4
8.9
31
73
N05CF02
ATC
zolpidem; oral
1.8
8.8
151
887
SPAT1235
SPAT
Mental health, emotional support
10.8
8.8
16
15
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
7.3
8.8
20
28
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
8.7
87
413
N06AA22
ATC
NA
14.2
8.7
14
10
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
50.5
8.7
10
*
F32.1
ICD-10 Finland
Moderate depressive episode
2.6
8.6
63
257
SPAT1139
SPAT
Nutrition survey
4.0
8.6
33
85
E22.1
ICD-10 Finland
Hyperprolactinaemia
8.3
8.6
18
22
F60.7
ICD-10 Finland
Dependent personality disorder
11.7
8.6
15
13
T07
ICPC
Weight gain
7.0
8.6
20
29
U01
ICPC
Dysuria/painful urination
2.7
8.5
58
227
R2
NOMESCO Finland
Guidance supporting rehabilitation
27.8
8.5
11
*
XA820
NOMESCO Finland
NA
27.8
8.5
11
*
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.4
8.5
29
67
N05AX16
ATC
brexpiprazole; oral
90.9
8.4
9
*
A46
ICD-10 Finland
Erysipelas
2.1
8.4
96
483
G72.8
ICD-10 Finland
Other specified myopathies
8.0
8.4
18
23
L16
ICPC
Ankle symptom/complaint
2.2
8.4
85
408
F23.2
ICD-10 Finland
Acute schizophrenia-like psychotic disorder
+∞
8.3
8
*
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
+∞
8.3
8
*
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
+∞
8.3
8
*
F20.14
ICD-10 Finland
Hepatic schizophrenia with partial recurrence
+∞
8.3
8
*
V400A
ICD-9 Finland
Mental and behavioural problems, Problems with learning
+∞
8.3
8
*
SPAT1216
SPAT
Assessment of functional ability
2.1
8.3
91
449
-58
ICPC
Therapeutic counselling/listening
8.6
8.3
17
20
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
8.3
27
708
S76
ICPC
Skin infection other
3.2
8.3
42
136
R29
ICPC
Respiratory symptom/complaint other
2.5
8.3
64
269
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
8.3
183
1166
WZA90
NOMESCO Finland
Other doctors statement
1.7
8.3
196
1272
N06AX26
ATC
vortioxetine; oral
2.4
8.2
66
283
G04BD07
ATC
tolterodine; oral
3.9
8.2
32
84
F60.5
ICD-10 Finland
Anankastic personality disorder
6.1
8.2
21
35
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
8.1
60
246
U02
ICPC
Urinary frequency/urgency
2.1
8.1
92
462
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.9
8.1
32
85
SPAT1272
SPAT
Drug screening
11.8
8.1
14
12
P45
ICPC
Psychological, Observ/health educat/advice/diet
33.7
8.1
10
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
8.0
164
1019
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.7
8.0
26
57
F05.8
ICD-10 Finland
Other delirium
22.2
8.0
11
5
F12.29
ICD-10 Finland
Addiction caused by cannabis UNS
22.2
8.0
11
5
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
22.2
8.0
11
5
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
8.0
128
736
U05
ICPC
Urination problems other
3.5
8.0
35
102
W78
ICPC
Pregnancy
0.4
8.0
34
799
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.0
338
2544
L03
ICPC
Low back symptom/complaint
1.7
7.9
193
1264
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.6
7.9
26
58
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
7.9
7.9
17
22
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
7.9
7.9
17
22
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.9
191
1248
H01
ICPC
Ear pain/earache
2.1
7.9
90
454
D01AC02
ATC
miconazole; topical
2.5
7.9
63
268
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
7.8
73
336
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.3
7.8
27
64
N02AJ06
ATC
codeine and paracetamol; systemic
0.6
7.7
166
2419
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.1
7.7
40
132
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.2
7.7
28
69
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
7.7
60
253
RT120
NOMESCO Finland
NA
45.4
7.7
9
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.7
7.7
32
89
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.1
7.7
41
138
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
7.7
132
776
K59.1
ICD-10 Finland
Functional diarrhoea
3.0
7.7
44
154
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
4.4
7.7
26
60
F31
ICD-10 Finland
Bipolar affective disorder
4.8
7.7
24
51
H29
ICPC
Ear symptom/complaint other
2.3
7.7
68
307
Z71.8
ICD-10 Finland
Other specified counselling
1.7
7.7
196
1299
SPAT1285
SPAT
Provision of consultation response
2.9
7.6
44
155
GD1AA
SPAT
NA
0.2
7.6
11
432
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.2
7.6
9
394
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
18.5
7.6
11
6
IEY03
NOMESCO Finland
Vocational rehabilitation
18.5
7.6
11
6
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
12.0
7.6
13
11
R1
NOMESCO Finland
Evaluation of the need and prospects for rehabilitation
25.2
7.6
10
*
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
9.0
7.6
15
17
N06AX17
ATC
milnacipran; oral
5.8
7.6
20
35
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
10.1
7.5
14
14
A01
ICPC
Pain general/multiple sites
2.4
7.5
61
261
J05AB11
ATC
valaciclovir; oral
0.4
7.5
23
620
L01
ICPC
Neck symptom/complaint
1.9
7.5
109
607
L02
ICPC
Back symptom/complaint
2.1
7.4
79
388
S74
ICPC
Dermatophytosis
5.1
7.4
22
44
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
80.7
7.4
8
*
F63.8
ICD-10 Finland
Other habit and impulse disorders
80.7
7.4
8
*
F30.20
ICD-10 Finland
Mania with mood-congruent psychotic symptoms
80.7
7.4
8
*
IFA99
SPAT
NA
80.7
7.4
8
*
2967A
ICD-9 Finland
Affective psychoses, Bipolar affective disorder, unspecified
80.7
7.4
8
*
R05
ICPC
Cough
1.7
7.4
172
1108
P17
ICPC
Tobacco abuse
5.3
7.4
21
40
-31
ICPC
Medical examin/health eval partial
2.6
7.4
54
219
N01
ICPC
Headache
2.0
7.4
91
475
SPAT1053
SPAT
Memory test
2.6
7.4
51
202
A10BH01
ATC
sitagliptin; oral
2.5
7.4
57
239
F63.0
ICD-10 Finland
Pathological gambling
11.0
7.3
13
12
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.0
7.3
40
138
F19.8
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, other mental and behavioural disorders
+∞
7.3
7
*
F19.53
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic
+∞
7.3
7
*
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
+∞
7.3
7
*
29500
ICD-8 Finland
Schizophrenia, Simple type
+∞
7.3
7
*
30199
ICD-8 Finland
Personality disorders, Unspecified
+∞
7.3
7
*
F19.40
ICD-10 Finland
Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures
+∞
7.3
7
*
F11.26
ICD-10 Finland
Addiction caused by opiates intermittent drug addiction
+∞
7.3
7
*
F34.0
ICD-10 Finland
Cyclothymia
9.5
7.3
14
15
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.4
7.3
28
689
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
5.2
7.3
21
41
IGY99
SPAT
NA
6.3
7.3
18
29
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
7.2
77
377
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.3
7.2
34
105
F50.8
ICD-10 Finland
Other eating disorders
15.9
7.2
11
7
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
15.9
7.2
11
7
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
7.2
199
1342
SPAT1281
SPAT
Other administrative function
2.3
7.2
65
295
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
7.4
7.2
16
22
SPAT1058
SPAT
PEF monitoring instruction
2.3
7.2
62
276
RK290
NOMESCO Finland
NA
30.3
7.2
9
*
IAB01
SPAT
NA
30.3
7.2
9
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
30.3
7.2
9
*
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
30.3
7.2
9
*
F31.2
ICD-10 Finland
Bipolar affective disorder, current episode manic with psychotic symptoms
30.3
7.2
9
*
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
30.3
7.2
9
*
B35.3
ICD-10 Finland
Tinea pedis
2.9
7.2
41
144
K10.3
ICD-10 Finland
Alveolitis of jaws
2.5
7.1
53
218
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
20.2
7.1
10
5
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
20.2
7.1
10
5
T74.1
ICD-10 Finland
Physical abuse
3.7
7.1
29
80
D19
ICPC
Teeth/gum symptom/complaint
1.6
7.1
221
1537
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
6.1
7.1
18
30
H03AA01
ATC
levothyroxine sodium; systemic
1.7
7.1
163
1047
H76
ICPC
Foreign body in ear
12.1
7.1
12
10
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.8
7.1
130
781
S17
ICPC
Abrasion/scratch/blister
4.4
7.1
24
56
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.0
7.0
38
130
R39.1
ICD-10 Finland
Other difficulties with micturition
3.7
7.0
29
81
G02BA03
ATC
plastic IUD with progestogen
0.4
7.0
27
663
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
7.0
162
1041
N06AX21
ATC
duloxetine; oral
2.0
6.9
88
465
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
6.9
99
544
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
5.5
6.9
19
35
J01FA15
ATC
telithromycin; oral
0.3
6.9
18
520
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
13.9
6.9
11
8
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.9
6.9
21
44
M01AE02
ATC
naproxen; oral, rectal
0.7
6.9
315
3965
R03AK07
ATC
formoterol and budesonide; inhalant
0.5
6.9
55
1042
L18
ICPC
Muscle pain
3.0
6.8
37
127
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.4
6.8
37
797
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
6.8
104
589
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
11.0
6.8
12
11
MAX99
NOMESCO Finland
Assistance to normal delivery
0.3
6.8
15
471
S93
ICPC
Sebaceous cyst
9.4
6.8
13
14
P63
ICPC
Psychological, Follow-up encounter unspecified
40.4
6.8
8
*
U13
ICPC
Bladder symptom/complaint other
4.3
6.8
23
54
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.7
6.7
43
163
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
22.7
6.7
9
*
Z01
ICPC
Poverty/financial problem
22.7
6.7
9
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
0.7
6.7
274
3523
A10AE04
ATC
insulin glargine; parenteral
2.1
6.7
75
376
K05.1
ICD-10 Finland
Chronic gingivitis
2.1
6.7
71
350
A06AC51
ATC
ispaghula, combinations; systemic
2.8
6.7
40
147
Z37.0
ICD-10 Finland
Single live birth
0.3
6.6
18
515
M79.6
ICD-10 Finland
Pain in limb
1.5
6.6
261
1915
Z10.0
ICD-10 Finland
Occupational health examination
0.2
6.6
9
360
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.1
6.6
75
381
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
8.8
6.6
13
15
A02BC01
ATC
omeprazole; systemic
1.6
6.6
181
1219
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
10.1
6.5
12
12
P79
ICPC
Phobia/compulsive disorder
10.1
6.5
12
12
A10BK03
ATC
empagliflozin; oral
2.4
6.5
52
223
SPAT1276
SPAT
Outlining of treatment with patient or their family members
4.5
6.5
21
47
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
6.4
240
1739
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
70.3
6.4
7
*
N05AA03
ATC
promazine; systemic
70.3
6.4
7
*
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
70.3
6.4
7
*
IAZ99
NOMESCO Finland
Other psychiatric consultation
70.3
6.4
7
*
G40.52
ICD-10 Finland
Epileptic seizures related to drugs
70.3
6.4
7
*
P71
ICPC
Organic psychosis other
70.3
6.4
7
*
3003A
ICD-9 Finland
Neurotic disorders, Obsessive-compulsive disorders
70.3
6.4
7
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
6.4
71
353
D07AA02
ATC
hydrocortisone; topical
1.8
6.4
116
693
L84
ICD-10 Finland
Corns and callosities
3.3
6.4
30
94
SPAT1342
SPAT
Referral to specialised care
6.6
6.3
15
23
F50.1
ICD-10 Finland
Atypical anorexia nervosa
8.2
6.3
13
16
R25.1
ICD-10 Finland
Tremor, unspecified
3.9
6.3
24
63
R03BB04
ATC
tiotropium bromide; inhalant
2.3
6.3
56
253
30799
ICD-8 Finland
Transient situational disturbances
18.2
6.3
9
5
F23.19
ICD-10 Finland
Acute polymorphic psychosis with schizophrenic disease picture UNS
+∞
6.3
6
*
F19.51
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid
+∞
6.3
6
*
29830
ICD-8 Finland
Other psychoses, Acute paranoid reaction
+∞
6.3
6
*
F20.29
ICD-10 Finland
Catat schizophrenia UNS
+∞
6.3
6
*
P55
ICPC
Psychological, Local injection/infiltration
+∞
6.3
6
*
F20.05
ICD-10 Finland
Paranoid schizophrenia with complete recurrence
+∞
6.3
6
*
2951C
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]
+∞
6.3
6
*
T43.3
ICD-10 Finland
Poisoning: Phenothiazine antipsychotics and neuroleptics
+∞
6.3
6
*
F11.9
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder
+∞
6.3
6
*
F22
ICD-10 Finland
Persistent delusional disorders
+∞
6.3
6
*
Z59.0
ICD-10 Finland
Homelessness
+∞
6.3
6
*
F23.09
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture UNS
+∞
6.3
6
*
F25.8
ICD-10 Finland
Other schizoaffective disorders
+∞
6.3
6
*
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
+∞
6.3
6
*
R3540
NOMESCO Finland
Rehabilitative work activities
+∞
6.3
6
*
RT130
NOMESCO Finland
NA
+∞
6.3
6
*
RF220
NOMESCO Finland
NA
4.8
6.2
19
40
IEV99
SPAT
NA
26.9
6.2
8
*
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
7.1
6.2
14
20
R96
ICPC
Asthma
2.2
6.2
59
277
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.0
6.2
82
438
SPAT1284
SPAT
Extensive health certificate
3.1
6.2
32
107
P58
ICPC
Psychological, Therapeutic counselling/listening
3.8
6.2
24
64
K03.66
ICD-10 Finland
Tooth plaque
2.2
6.2
58
269
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
6.2
95
537
G04BD12
ATC
mirabegron; oral
2.3
6.2
55
249
R73.0
ICD-10 Finland
Abnormal glucose tolerance test
4.3
6.1
21
50
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
6.1
67
333
SPAT1196
SPAT
Monitoring of normal pregnancy
0.3
6.1
9
349
3092D
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]
12.6
6.1
10
8
SPAT1229
SPAT
Assessment of need for aid
2.5
6.1
46
191
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
6.1
267
1999
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
4.4
6.1
20
46
X78
ICD-10 Finland
Intentional self-harm by sharp object
6.8
6.0
14
21
K08.80
ICD-10 Finland
Toothache NOS
2.0
6.0
75
394
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.8
6.0
99
573
R33
ICD-10 Finland
Retention of urine
2.7
6.0
39
149
N03AX16
ATC
pregabalin; oral
1.6
6.0
157
1041
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.7
6.0
24
66
E66.9
ICD-10 Finland
Obesity, unspecified
2.8
6.0
35
126
N02AX02
ATC
tramadol; systemic, rectal
0.7
6.0
166
2314
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
151
78
22.88
198.91
7.5
5.3
umol/l
403.0
360.3
1.88
134
68
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
69
45
16.47
80.15
13.3
8.8
mmol/l
0.6
0.6
0.28
60
40
(3028707) Methadone [Presence] in Urine by Screen method
110
191
6.39
61.98
6.5
2.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
242
865
3.42
54.04
1.8
1.6
nmol/l
1074.2
1175.2
1.06
182
672
(4198724)
48
33
15.28
53.96
5.9
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
484
2616
2.75
50.54
4.7
6.1
mmol/l
1.2
1.2
0.28
449
2400
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
476
2596
2.69
48.14
4.4
3.3
u/l
30.8
32.1
0.31
448
2480
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
298
1303
2.89
46.10
2.6
1.8
%
1.6
1.4
5.24
264
1185
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
508
2931
2.60
44.74
5.2
6.7
mmol/l
1.2
1.2
0.31
417
2485
(3015377) Calcium [Moles/volume] in Serum or Plasma
391
2003
2.63
43.94
2.4
3.2
mmol/l
2.3
2.4
0.62
350
1805
(3009508) Creatinine [Moles/volume] in Urine
375
1926
2.58
41.39
4.1
3.2
mmol/l
7.5
8.5
2.79
313
1643
(3018418) pH of Serum or Plasma
342
1729
2.54
38.48
3.0
4.1
ph
7.4
7.4
0.12
77
331
(3021960) Folate [Moles/volume] in Serum or Plasma
270
1220
2.70
38.24
1.7
1.4
nmol/l
19.1
21.2
1.48
251
1066
(3013650) Neutrophils [#/volume] in Blood by Automated count
621
4172
2.44
36.12
29.8
7.8
e9/l
4.2
4.0
2.71
569
3664
(3011288) Drugs identified in Urine by Screen method
118
338
3.85
36.06
7.7
2.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
382
2086
2.40
35.74
2.9
2.6
u/l
47.6
57.4
7.46
331
1964
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
408
2307
2.36
35.09
2.1
1.7
pmol/l
102.6
97.4
1.24
231
1248
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
765
5702
2.84
35.08
5.2
3.8
pmol/l
14.6
14.5
0.16
716
5312
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
859
6847
3.99
34.69
6.7
4.3
mu/l
1.9
2.1
0.55
813
6434
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
733
5384
2.65
33.97
7.4
7.1
u/l
79.0
74.9
2.17
698
5098
(42870588) Differential panel, method unspecified - Blood
404
2308
2.32
33.55
8.2
6.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
255
1187
2.58
33.44
1.7
1.6
pmol/l
115668643.3
32202172.1
0.50
217
1031
(3001604) Monocytes [#/volume] in Blood
556
3643
2.29
33.02
10.2
5.6
e9/l
0.6
0.6
1.90
478
3214
(3006315) Basophils [#/volume] in Blood
557
3655
2.29
32.92
10.6
5.6
e9/l
0.0
0.0
0.16
478
3225
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
27
16
17.34
32.50
2.1
2.2
umol/l
13.5
14.8
0.19
27
16
(1001926) Buprenorphine [Presence] in Urine by Screen method
125
402
3.43
32.00
6.1
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
568
3787
2.27
31.89
13.6
5.7
e9/l
0.2
0.2
1.81
504
3378
(3044889) 12 lead EKG panel
675
4864
2.38
31.07
4.7
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
560
3782
2.19
29.50
10.5
5.6
e9/l
2.1
1.9
2.09
486
3402
(40758558) Short blood count panel - Blood
321
1748
2.27
29.00
16.3
5.9
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
27
0
+∞
28.27
8.9
0.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
894
7547
4.85
28.24
18.4
11.3
mmol/l
139.5
139.7
1.64
880
7352
(21494755) Public health laboratory ask at order entry panel
14
1356
0.09
27.92
1.2
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
893
7573
4.66
27.12
18.2
11.4
mmol/l
4.0
3.9
1.47
879
7360
(3019150) Specific gravity of Urine by Refractometry
279
1476
2.27
26.66
5.0
2.9
kg/l
1.0
1.0
0.28
35
189
(3016879) Cocaine [Presence] in Urine
130
481
2.98
26.13
5.7
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
555
3853
2.08
25.72
5.1
4.6
mmol/l
6.8
6.6
1.29
511
3569
(3020682) Albumin/Creatinine [Ratio] in Urine
307
1723
2.16
25.08
3.6
4.1
mg/mmol
3.3
9.9
4.88
177
1116
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
861
7225
3.31
24.65
6.5
3.6
mmol/l
6.2
5.8
11.18
820
6755
(3000764) Benzodiazepines [Presence] in Urine
132
519
2.80
23.64
6.0
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
132
526
2.76
23.02
6.1
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
598
4362
2.02
23.00
5.2
3.5
e6/l
4995.4
450.6
0.46
13
48
(3012516) Albumin [Mass/volume] in Urine
290
1641
2.11
22.83
3.0
3.3
mg/l
487.1
308.7
0.22
171
1068
(3027008) Opiates [Presence] in Urine
131
524
2.74
22.66
6.1
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
503
3484
1.96
22.15
5.2
6.1
umol/l
9.0
11.2
5.17
452
3316
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
429
2819
1.96
22.04
2.6
2.2
nmol/l
68.1
73.9
4.41
398
2601
(3026008) Bacteria identified in Urine by Culture
275
1546
2.10
21.89
3.4
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
271
1518
2.10
21.76
3.7
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
69
194
3.76
21.47
1.3
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
402
2634
1.92
20.38
3.8
4.9
g/l
35.6
36.9
3.73
365
2475
(3029937) Albumin [Presence] in Urine by Test strip
304
1818
1.99
20.13
4.3
3.1
estimate
0.0
0.0
1.08
83
676
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
811
6777
2.44
20.08
7.1
4.6
mmol/mol
39.6
38.6
1.91
764
6443
(3023511) Choriogonadotropin [Units/volume] in Urine
68
201
3.57
19.65
1.7
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
475
3318
1.87
19.48
9.8
5.8
%
0.6
0.7
3.08
437
3124
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
1150
0.16
19.33
1.4
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
123
515
2.60
19.33
5.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94
342
2.94
19.32
1.8
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
643
0.09
19.30
2.2
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
207
3483
0.48
19.20
3.3
2.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
489
3460
1.86
19.13
10.8
5.9
%
8.2
8.4
1.07
451
3278
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
304
1850
1.95
18.93
2.6
2.0
u/l
409.4
221.7
0.85
283
1756
(3006504) Eosinophils/100 leukocytes in Blood
485
3440
1.85
18.66
10.0
5.7
%
2.4
2.9
5.49
444
3232
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
305
1867
1.94
18.61
1.8
1.6
mmol/l
1.8
1.4
4.75
254
1619
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
173
866
2.22
18.18
2.0
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
496
3599
1.80
17.18
10.3
5.7
%
29.4
29.1
0.22
455
3402
(3019060) Gas panel - Arterial blood
87
326
2.84
16.92
4.6
6.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
489
3554
1.78
16.66
9.9
5.5
%
56.8
56.5
0.27
442
3375
(3023368) Bacteria identified in Blood by Culture
252
1503
1.92
16.28
4.4
4.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
449
3225
1.75
15.57
12.5
8.3
e9/l
0.0
0.0
0.69
368
2656
(3021387) Prolactin [Units/volume] in Serum or Plasma
97
404
2.56
15.32
1.9
1.5
mu/l
629.0
249.8
5.53
82
367
(3008152) Bicarbonate [Moles/volume] in Arterial blood
81
308
2.78
15.31
7.2
8.9
mmol/l
25.9
24.5
1.73
75
289
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
127
599
2.30
15.26
2.0
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
241
1447
1.90
15.11
2.1
2.0
mg/l
2.9
2.8
0.26
201
1255
(3037467) Urinalysis macro (dipstick) panel - Urine
616
4866
1.77
15.02
4.6
3.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
39
1232
0.29
14.64
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
124
593
2.26
14.39
6.4
9.7
mmol/l
2.5
1.0
2.94
93
477
(3017509) Phencyclidine [Presence] in Urine
14
11
12.90
14.28
1.9
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
53
5.41
14.25
2.1
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
123
590
2.25
14.17
2.0
1.7
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
30
7.14
14.02
1.7
3.0
umol/l
172.6
168.6
—
9
16
(3012095) Magnesium [Moles/volume] in Serum or Plasma
176
976
1.99
13.85
2.2
3.6
mmol/l
0.8
0.8
1.75
163
928
(40761535) Cells panel - Urine sediment
104
469
2.37
13.82
3.2
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
46
135
3.53
13.45
2.1
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
697
5800
1.78
13.20
5.3
2.9
u/l
46.2
44.6
0.25
660
5549
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
171
961
1.95
12.88
2.2
2.7
mmol/l
2.4
2.4
0.11
153
841
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
792
0.18
12.80
1.2
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
120
597
2.16
12.59
6.4
9.6
kpa
5.4
5.1
1.93
114
570
(3027801) Oxygen [Partial pressure] in Arterial blood
120
597
2.16
12.59
6.4
9.5
kpa
11.0
13.0
4.21
114
573
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
99
456
2.31
12.52
2.6
4.2
mmol/l
1.2
1.2
0.34
83
401
(3002173) Hemoglobin [Mass/volume] in Arterial blood
105
496
2.26
12.51
6.5
10.8
g/l
123.2
124.1
0.15
100
480
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
42
127
3.42
11.75
1.9
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
334
2345
1.66
11.67
3.8
2.9
ng/l
16.1
42.2
2.47
218
1317
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
70
285
2.57
11.57
1.9
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
462
3521
1.61
11.56
4.0
2.9
estimate
0.0
0.0
0.00
80
674
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
11
0
+∞
11.48
1.5
0.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
319
2235
1.65
11.13
3.1
2.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
27
62
4.45
11.03
1.5
1.5
mosm/kgh2o
284.5
286.0
0.10
20
49
(3003458) Phosphate [Moles/volume] in Serum or Plasma
141
783
1.94
10.91
3.1
6.4
mmol/l
1.0
1.0
0.27
130
740
(3042517) Benzodiazepines panel - Urine
16
9
18.06
10.75
1.9
3.2
—
—
—
0
0
(3020891) Body temperature
53
200
2.75
10.19
5.5
4.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
13
9.34
9.89
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
200
1273
1.73
9.87
2.4
2.4
e6/l
8.8
6.1
1.27
178
1111
(3009343) pH of Capillary blood
77
354
2.28
9.77
3.6
2.9
ph
7.4
7.4
—
9
53
(3021601) Nitrite [Presence] in Urine by Test strip
453
3528
1.55
9.73
4.8
4.1
estimate
0.0
0.0
0.50
85
696
(3020191) Ethanol [Moles/volume] in Serum or Plasma
27
69
4.00
9.64
1.4
1.6
promille
1.1
1.5
0.43
18
55
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
74
338
2.29
9.54
3.6
2.9
mmol/l
1.8
1.5
0.33
52
244
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
130
735
1.89
9.48
6.9
5.2
—
—
—
0
0
(3010421) pH of Blood
43
153
2.90
9.23
3.0
3.6
ph
7.4
7.4
1.02
37
131
(3023183) Ammonium ion [Moles/volume] in Plasma
38
126
3.10
9.21
2.0
3.9
umol/l
28.9
35.6
1.42
29
109
(3002582) Erythrocytes [#/volume] in Urine
268
1871
1.61
9.16
3.1
2.8
e6/l
42.0
75.2
0.39
217
1412
(3022217) INR in Platelet poor plasma by Coagulation assay
111
602
1.96
9.16
13.1
14.7
inr
1.4
1.2
—
9
96
(3012501) Base excess in Blood by calculation
39
132
3.04
9.13
3.0
3.6
mmol/l
3.1
2.4
0.45
25
89
(3013512) EKG study
243
1658
1.63
9.12
3.5
3.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
112
611
1.95
9.08
4.1
3.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
855
7821
2.04
9.08
5.7
4.1
mmol/l
2.7
2.9
7.90
798
7399
(40760892) CBC W Ordered Manual Differential panel - Blood
264
1844
1.60
8.98
8.2
4.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
312
2270
1.56
8.89
3.8
3.2
e6/l
56.4
82.2
0.48
228
1539
(3009261) Glucose [Presence] in Urine by Test strip
451
3555
1.52
8.87
4.0
2.9
estimate
0.0
0.0
0.50
80
650
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
8
0
+∞
8.34
1.9
0.0
nmol/l
29.5
—
—
8
0
(3013707) Erythrocyte sedimentation rate by Westergren method
631
5382
1.53
8.23
3.8
3.8
mm/h
11.0
9.2
2.83
584
5061
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
890
8316
2.35
8.13
12.6
8.9
u/l
30.0
29.3
0.41
873
8111
(3027945) Reticulocytes/100 erythrocytes in Blood
98
535
1.93
7.93
2.1
2.8
%
1.8
1.7
0.25
87
481
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
538
6254
0.67
7.91
3.2
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
844
7751
1.88
7.90
5.3
3.8
mmol/l
4.5
4.8
15.77
790
7373
(3030467) Casts [#/volume] in Urine by Automated count
245
1728
1.57
7.85
3.0
2.7
e6/l
0.3
0.4
0.03
193
1275
(3003181) Sodium [Moles/volume] in Urine
23
62
3.78
7.66
1.1
1.3
mmol/l
64.9
66.3
0.04
15
56
(3026782) Osmolality of Urine
180
1191
1.63
7.51
2.5
2.5
mosm/kgh2o
473.7
560.1
4.75
148
1015
(36304419) Bacteria [Presence] in Urine
242
1724
1.54
7.35
2.8
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
815
7440
1.72
7.35
4.6
3.5
mmol/l
1.6
1.3
16.09
760
7046
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
66
3.55
7.02
4.0
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
130
805
1.71
6.96
1.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
169
1124
1.61
6.87
3.3
3.2
ng/l
43.6
692.4
3.52
111
739
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
548
0.28
6.79
1.3
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
73
383
1.98
6.64
2.5
2.3
u/l
32.9
3348.2
2.94
21
159
(40767503) Oxygen content in Capillary blood by calculation
31
111
2.85
6.63
2.3
2.3
%
16.6
16.9
0.15
14
63
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
836
7731
1.74
6.60
5.1
3.8
mmol/l
1.3
1.4
27.34
781
7328
(3014111) Lactate [Moles/volume] in Serum or Plasma
90
508
1.85
6.58
5.3
7.9
mmol/l
1.4
1.3
0.27
85
492
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
835
7722
1.73
6.56
16.2
10.8
mg/l
19.9
21.3
0.62
673
5932
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
191
1334
1.54
6.25
2.3
2.9
ng/l
998.8
729.2
0.24
148
1083
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
82
457
1.87
6.25
1.7
3.8
pmol/l
4.4
4.6
1.08
64
413
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
351
2776
1.42
6.09
4.3
2.9
—
—
—
0
0
(4024509)
15
35
4.34
6.04
1.9
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
1176
0.53
5.98
2.3
2.3
ug/l
0.4
0.7
6.98
48
590
(3000034) Microalbumin [Mass/volume] in Urine
18
49
3.73
5.94
2.7
2.8
mg/l
7.4
17.5
1.17
11
34
(3017181) Myelocytes/100 leukocytes in Blood
96
573
1.75
5.85
6.6
4.0
%
0.5
0.9
0.81
33
161
(3023520) Reticulocytes [#/volume] in Blood
69
375
1.91
5.69
2.5
3.0
e9/l
75.2
71.3
0.27
54
270
(4146454)
19
56
3.44
5.60
2.8
2.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
139
926
1.59
5.57
1.9
2.4
umol/l
12.9
14.8
2.30
125
863
(3017143) Hepatitis C virus Ab [Presence] in Serum
169
1180
1.53
5.50
1.9
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
19
57
3.38
5.46
3.6
9.6
mmol/l
6.6
7.2
0.39
14
50
(3014007) Fractional oxyhemoglobin in Arterial blood
62
330
1.94
5.44
7.6
11.8
%
92.9
94.4
1.67
62
330
(3000494) Fungus identified in Specimen by Culture
129
851
1.60
5.38
1.5
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
18
5.60
5.33
6.0
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
18
5.60
5.33
6.0
3.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
785
7236
1.52
5.26
14.0
9.5
ml/min/173m2
94.4
90.4
5.68
597
5920
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
74
424
1.81
5.19
2.4
2.2
ug/l
4.9
8.6
2.52
61
390
(3004809) Band form neutrophils/100 leukocytes in Blood
25
93
2.73
5.04
2.0
2.8
%
1.1
1.4
0.30
17
79
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
310
0.28
4.98
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
311
0.28
4.97
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
311
0.28
4.97
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
312
0.28
4.97
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
66
3.07
4.97
2.1
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
127
857
1.56
4.80
1.9
2.4
g/l
2.5
2.4
1.88
114
797
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
72
420
1.77
4.77
1.6
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
293
2325
1.38
4.74
6.3
6.5
inr
1.1
1.1
0.70
132
742
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
55
297
1.90
4.66
7.1
13.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
86
533
1.68
4.60
5.1
3.9
%
0.4
0.5
0.20
20
123
(3050129) First trimester maternal screen panel - Serum or Plasma
11
369
0.29
4.55
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
119
804
1.55
4.48
1.9
2.8
umol/l
5.9
8.2
1.07
77
709
(3017732) Neutrophils [#/volume] in Blood
83
518
1.66
4.34
5.9
2.0
e9/l
4.4
4.1
0.64
71
439
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
88
560
1.63
4.26
1.9
2.4
g/l
0.2
0.2
0.21
79
527
(3000492) Spirometry study
55
934
0.56
4.20
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
91
2.57
4.15
2.1
2.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
38
188
2.06
4.14
2.3
2.1
ug/l
320.5
296.7
0.08
31
176
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
334
0.29
4.13
1.6
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
727
6697
1.38
4.07
31.0
12.5
%
13.7
13.5
3.99
718
6569
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
141
1008
1.47
4.06
2.7
2.4
e6/l
1.0
1.0
0.09
76
549
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
48
261
1.88
4.02
3.2
3.0
mmol/l
24.4
24.1
0.24
42
240
(3036481) Cortisol [Moles/volume] in Serum or Plasma
102
683
1.55
4.00
1.6
2.0
nmol/l
367.7
357.4
0.25
93
639
(3016650) Hepatitis A virus Ab [Presence] in Serum
33
157
2.14
3.98
1.3
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
73
451
1.67
3.98
5.8
9.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
226
0.26
3.95
1.7
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
100
669
1.55
3.94
3.1
2.5
u/l
25.2
105.9
0.61
80
583
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
151
2.16
3.94
1.6
2.6
ug/min
167.5
104.9
0.27
14
96
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
259
0.30
3.88
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
251
0.31
3.75
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
179
2311
0.72
3.75
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
253
0.31
3.75
1.5
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
237
1879
1.35
3.74
1.4
1.3
u/ml
1.9
1.8
0.05
69
550
(3021440) Promyelocytes/100 leukocytes in Blood
84
549
1.58
3.67
7.2
4.0
%
0.0
0.1
1.53
29
147
(3020779) Urea [Moles/volume] in Serum or Plasma
78
502
1.60
3.64
4.2
8.3
mmol/l
6.4
7.8
1.60
73
480
(3009542) Hematocrit [Volume Fraction] of Blood
726
7718
0.74
3.57
28.3
10.7
%
40.7
41.3
1.10
430
6402
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
195
0.25
3.57
1.0
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
112
785
1.48
3.57
2.0
2.5
%
20.5
25.1
2.50
89
685
(3007463) Buprenorphine [Presence] in Urine
6
6
10.05
3.50
1.7
4.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
80
524
1.58
3.48
7.7
4.0
%
0.0
0.1
1.41
22
128
(3042936) Bacteria identified in Isolate by Culture
124
899
1.44
3.32
1.8
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
394
0.42
3.30
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
44
250
1.80
3.25
3.0
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
175
1355
1.36
3.19
2.4
2.0
—
—
—
0
0
(1002224) Polysomnography panel
25
493
0.49
3.15
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
111
2.19
3.15
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
111
2.19
3.15
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
145
2.03
3.13
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
489
1.56
3.12
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
128
951
1.40
3.00
3.0
2.5
e6/l
6.5
2.2
2.09
63
494
(3020491) Glucose [Moles/volume] in Blood
15
57
2.66
2.97
1.3
1.6
mmol/l
6.6
6.5
—
5
41
(3014051) Protein [Presence] in Urine by Test strip
28
142
2.00
2.92
2.2
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
58
2.61
2.88
1.9
2.4
%
61.7
58.1
—
6
42
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
164
1.92
2.88
2.5
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
281
3305
0.79
2.86
4.2
3.8
—
—
—
0
0
(4010399)
69
464
1.53
2.72
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
47
288
1.67
2.71
1.6
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
39
227
1.75
2.70
3.2
3.2
mmol/l
24.3
24.7
0.85
39
219
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
265
0.37
2.69
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
857
8244
1.45
2.69
18.7
9.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
88
625
1.45
2.66
3.3
3.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
61
2.48
2.63
1.1
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
180
1.81
2.50
2.9
3.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
44
272
1.65
2.48
2.5
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
104
773
1.39
2.45
5.0
3.7
%
29.3
30.6
0.67
81
555
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
153
1.86
2.40
6.4
4.2
%
57.5
57.0
0.09
28
153
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
1608
0.76
2.25
2.3
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
66
460
1.47
2.23
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
150
1.82
2.22
6.1
3.8
e9/l
4.4
4.2
0.15
27
150
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
9
5.58
2.21
1.0
1.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
9
5.58
2.21
1.0
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
76
546
1.43
2.19
3.6
2.2
ml/min/173m2
75.9
76.0
0.01
27
217
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
182
1499
1.27
2.11
2.4
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
206
1.67
2.10
1.8
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
202
1689
1.25
2.05
1.9
1.7
mg/l
2.0
0.9
0.64
142
1255
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
121
949
1.32
2.04
1.8
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
62
860
0.70
1.98
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
51
2.37
1.95
1.9
1.6
%
13.4
11.2
0.90
12
51
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
172
1.71
1.95
1.4
2.9
nmol/l
1.2
0.9
1.40
22
149
(44806071)
5
11
4.56
1.94
1.4
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
6
16
3.77
1.93
2.7
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
58
407
1.45
1.92
4.2
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
26
150
1.75
1.92
1.4
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
44
293
1.53
1.88
7.8
11.9
mmol/l
25.1
24.4
0.53
39
280
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
222
1.60
1.84
2.2
1.8
—
—
—
0
0
(4035726)
34
523
0.64
1.84
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
36
231
1.58
1.81
1.5
1.4
titre
52.0
75.9
—
5
27
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
51
354
1.47
1.80
1.9
2.8
ng/l
224.0
141.5
0.45
41
309
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
167
0.41
1.80
7.0
5.9
—
387.3
—
0
23
(3007461) Platelets [#/volume] in Blood
906
8883
1.57
1.78
37.6
15.1
e9/l
258.6
255.0
0.91
892
8695
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
31
2.59
1.66
1.0
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
906
8893
1.53
1.64
37.5
15.0
fl
89.9
90.2
1.44
896
8803
(3035941) MCH [Entitic mass]
906
8894
1.53
1.63
37.3
15.0
pg
30.0
30.2
4.06
896
8803
(3026361) Erythrocytes [#/volume] in Blood
906
8895
1.53
1.62
37.6
15.1
e12/l
4.6
4.6
0.03
889
8696
(3048689) Calprotectin [Mass/mass] in Stool
133
1091
1.26
1.61
2.1
2.6
ug/g
92.2
131.9
1.52
98
886
(3045414) Leukocytes [Presence] in Urine
45
313
1.46
1.60
2.0
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
77
1.96
1.60
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
70
2.02
1.59
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
906
8897
1.52
1.59
37.8
15.1
g/l
138.2
139.5
1.97
896
8804
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
25
152
1.66
1.58
1.4
1.4
u/l
21.1
21.6
0.02
16
126
(3010813) Leukocytes [#/volume] in Blood
906
8900
1.51
1.55
38.1
15.1
e9/l
7.2
6.6
11.10
891
8695
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
21
2.87
1.50
2.5
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
162
1.62
1.50
1.0
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
125
0.40
1.50
1.2
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
242
0.53
1.49
1.2
1.6
g/l
0.2
0.2
0.02
13
233
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
14
253
0.55
1.46
1.1
1.6
g/l
1.3
1.2
0.46
14
243
(46235355) HIV 1 and 2 tests - Meaningful Use set
235
2064
1.18
1.44
2.4
1.9
—
—
—
0
0
(3019225) pH of Specimen
71
545
1.33
1.44
3.3
4.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
22
2.74
1.43
1.3
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
67
1.95
1.38
1.2
1.2
nmol/l
1.7
1.3
1.02
13
61
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
158
1.60
1.38
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
55
409
1.37
1.38
2.7
4.0
ng/l
72.0
80.2
0.35
40
369
(3001122) Ferritin [Mass/volume] in Serum or Plasma
369
3372
1.16
1.37
2.7
2.7
ug/l
152.5
109.7
0.44
339
3188
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
246
0.56
1.34
1.4
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
11
54
2.05
1.33
1.3
1.1
ratio
1.0
1.1
—
5
21
(3026493) Urate [Moles/volume] in Serum or Plasma
158
1836
0.83
1.32
1.9
2.4
umol/l
338.7
4940.2
5.28
129
1647
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
41
0.00
1.31
0.0
1.6
—
5.0
—
0
32
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
187
1624
1.19
1.31
1.8
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
185
2118
0.84
1.30
2.2
2.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
14
76
1.85
1.30
2.1
3.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
34
2.36
1.29
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
132
0.45
1.29
1.2
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
202
1.50
1.28
1.3
1.2
—
—
—
0
0
(44813793)
10
48
2.09
1.28
1.1
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
44
2.06
1.27
1.1
1.3
u/l
183.2
649.5
—
9
38
(3004588) Protein electrophoresis panel - Serum or Plasma
45
329
1.39
1.26
1.6
2.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
34
237
1.45
1.24
1.5
1.4
—
1824.0
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
94
767
1.25
1.23
2.1
2.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
11
56
1.98
1.22
1.8
1.6
mg/l
16.6
16.7
—
5
16
(3051593) INR in Capillary blood by Coagulation assay
5
19
2.64
1.21
7.2
13.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
287
0.62
1.21
1.3
1.5
—
—
—
0
0
(4094501)
11
199
0.55
1.18
1.3
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
64
1.89
1.18
4.5
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
110
1308
0.82
1.17
1.2
1.3
u/ml
9.8
10.7
0.04
27
548
(40768804) Tissue Pathology biopsy report
258
2853
0.87
1.16
1.8
2.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
17
271
0.62
1.15
1.4
1.6
iu/ml
0.0
0.1
—
5
45
(3034426) Prothrombin time (PT)
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(4034850)
32
225
1.44
1.13
9.1
8.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
52
398
1.32
1.12
1.6
2.6
g/l
67.0
67.9
0.35
47
374
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
21
135
1.57
1.12
1.2
1.1
iu/ml
1.2
3372.9
—
6
38
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
21
2.39
1.09
4.6
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
202
1.45
1.08
1.4
1.4
ug/g
277.0
307.2
0.28
13
107
(3006653) Thiamine [Moles/volume] in Blood
7
32
2.20
1.08
1.4
1.3
nmol/l
165.3
146.2
—
7
32
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
97
1.66
1.07
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
178
1.47
1.06
1.7
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
37
271
1.38
1.06
2.4
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
135
1559
0.84
1.06
3.1
3.1
%
21.8
21.1
0.18
48
537
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
202
0.59
1.02
1.3
1.1
u/ml
0.4
2.3
—
6
80
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
74
603
1.25
1.01
1.8
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
110
0.45
1.00
1.4
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
118
1370
0.84
0.99
1.2
1.3
iu/ml
21.4
25.9
0.36
25
445
(3025941) Bacteria identified in Stool by Culture
58
460
1.28
0.99
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
159
0.56
0.99
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
81
669
1.23
0.98
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
165
1.47
0.97
2.0
2.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
124
1.54
0.97
1.8
2.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
31
421
0.73
0.96
1.6
1.9
mg/l
3.8
3.8
0.00
25
290
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
77
1.70
0.95
1.4
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
32
0.00
0.95
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
32
0.00
0.95
0.0
1.0
—
37.5
—
0
32
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
102
1.58
0.91
1.8
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
129
0.54
0.88
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
79
1.65
0.88
1.5
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
31
1.94
0.84
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
28
206
1.37
0.82
1.6
2.2
g/l
1.7
1.4
0.88
22
181
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
248
0.68
0.81
1.7
2.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
81
1.61
0.81
1.3
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
93
797
1.19
0.80
1.7
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
183
1651
1.13
0.80
1.4
1.4
g/l
2.2
2.4
0.45
101
1097
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
26
0.00
0.78
0.0
1.0
—
125.0
—
0
26
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
26
0.00
0.78
0.0
1.0
—
102.5
—
0
16
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
124
0.56
0.78
2.6
3.1
—
2877.7
—
0
10
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
174
1918
0.89
0.74
1.6
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.2
—
69.5
—
0
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
84
1.56
0.72
1.3
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
41
1.71
0.70
1.7
3.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
239
0.71
0.69
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
162
1.37
0.66
3.2
2.8
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
4.0
2.9
umol/l
24.4
33.3
—
5
19
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
155
0.64
0.66
1.1
1.1
—
11.6
—
0
15
(3005322) IgE [Units/volume] in Serum or Plasma
45
547
0.81
0.66
1.2
1.3
u/ml
371.3
254.5
0.18
40
509
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
599
1.18
0.64
1.2
1.2
iu/ml
167.8
151.6
0.12
25
246
(3003327) Ova and parasites identified in Stool by Light microscopy
36
287
1.26
0.64
1.3
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
95
1.48
0.64
1.4
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
17
235
0.72
0.64
1.8
2.4
%
154.6
179.1
0.86
17
225
(40768797) Stomach Pathology biopsy report
108
958
1.14
0.63
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
138
1.38
0.63
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
147
1.37
0.62
2.0
3.3
u/ml
0.3
0.3
0.66
13
71
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
289
1.26
0.61
1.5
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
30
1.67
0.61
1.0
3.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
100
1125
0.88
0.60
1.4
1.4
titre
336.0
488.3
0.98
15
232
(3000060) B lymphocytes [#/volume] in Blood
0
20
0.00
0.60
0.0
1.9
—
221.8
—
0
11
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
53
1.51
0.58
1.6
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
23
0.00
0.58
0.0
1.4
—
8.8
—
0
23
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.56
1.2
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.56
1.2
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
88
0.57
0.56
1.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
503
0.83
0.55
3.6
4.6
ug/l
68.6
21.0
0.42
34
402
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
148
0.67
0.55
1.3
1.2
u/ml
2.2
4.3
—
5
57
(3042631) Mycobacterium sp identified in Specimen
11
74
1.49
0.53
2.3
3.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
134
1.35
0.53
4.3
3.3
mg/l
26.7
27.7
0.03
12
78
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
146
1337
1.11
0.53
1.6
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
97
0.62
0.52
1.7
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
101
908
1.13
0.51
1.7
2.2
s
30.3
29.6
0.58
96
885
(3016018) Differential panel - Cerebral spinal fluid
11
75
1.47
0.51
1.0
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
1.2
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
41
1.47
0.50
1.2
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
17
224
0.75
0.50
2.2
2.5
g/l
3.6
3.7
0.05
17
214
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
171
1.29
0.50
1.8
1.9
g/l
2.9
3.0
0.34
16
142
(40760888) Immunoglobulin light chains.free panel - Serum
15
110
1.37
0.49
2.1
4.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
12
166
0.72
0.48
1.1
1.5
nmol/l
0.6
0.4
—
7
140
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
111
1.36
0.47
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.6
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.6
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
84
0.59
0.45
1.4
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
121
0.66
0.45
2.5
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
104
1142
0.90
0.45
2.0
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
326
0.82
0.41
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
33
1.52
0.41
1.0
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
2.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.7
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
6.5
—
0
16
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
17
0.00
0.40
0.0
1.1
—
86.0
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
17
0.00
0.40
0.0
1.1
—
78.8
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
18
0.00
0.40
0.0
2.4
—
—
—
0
0
(4268621)
7
101
0.69
0.39
2.0
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
1.6
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
182
0.77
0.39
1.2
1.2
—
36.6
—
0
14
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
242
1.20
0.39
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
115
1.31
0.39
1.2
1.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
225
0.80
0.38
1.2
1.2
—
15.9
—
0
13
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
243
1.20
0.38
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
354
0.84
0.37
1.5
1.4
u/l
7.8
7.7
0.02
21
295
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
111
0.72
0.37
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
37
1.35
0.37
2.0
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
81
1.36
0.36
1.2
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
245
1.19
0.35
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
292
1.17
0.35
1.3
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
39
340
1.15
0.34
1.7
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
91
1.32
0.34
1.7
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
228
1.19
0.33
4.6
4.0
g/l
0.1
0.2
—
8
103
(3000093) Morphology [Interpretation] in Blood Narrative
6
46
1.31
0.33
1.7
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
17
209
0.81
0.32
1.2
1.2
—
14.0
—
0
36
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
52
579
0.89
0.31
2.1
2.3
—
19.9
—
0
43
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.6
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
184
1.20
0.30
1.8
1.8
g/l
3.7
3.9
0.32
16
138
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
184
1.20
0.30
1.8
1.8
g/l
7.1
7.2
0.12
17
149
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
184
1.20
0.30
1.8
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
207
0.82
0.30
1.2
1.2
—
3.1
—
0
23
(40768793) Breast Pathology biopsy report
19
157
1.21
0.29
1.4
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
63
1.27
0.27
2.3
2.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
116
0.77
0.27
4.1
3.6
u/ml
3.5
39.3
—
9
105
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
132
1.22
0.26
1.7
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
55
601
0.91
0.25
1.7
2.7
g/l
10.8
10.6
0.20
49
549
(3017446) Testosterone [Moles/volume] in Serum or Plasma
73
786
0.92
0.24
2.8
2.3
nmol/l
14.5
14.1
0.15
64
725
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
17
142
1.20
0.24
2.1
3.5
ratio
1.2
2.0
—
5
17
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
204
1961
1.05
0.24
3.0
3.3
ug/l
1.3
1.7
1.33
177
1811
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
78
1.29
0.24
1.0
1.1
mg/l
294.2
285.4
—
10
73
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
78
1.29
0.24
1.9
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
106
1.23
0.23
1.7
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
88
1.25
0.22
1.0
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
94
0.74
0.22
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
263
0.87
0.22
1.1
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.3
—
0.4
—
0
10
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
1.6
—
0
12
(3032057) Clostridioides difficile [Presence] in Stool
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
145
0.83
0.21
1.5
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
49
1.23
0.20
2.8
2.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
49
1.23
0.20
1.2
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
165
0.85
0.19
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
51
1.18
0.19
1.8
2.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
196
0.86
0.18
1.2
1.2
u/ml
157.2
253.4
—
10
127
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
60
1.17
0.18
3.0
2.3
pg
32.6
33.5
—
7
60
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
91
1.21
0.17
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
204
2102
0.96
0.17
3.6
2.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
205
0.88
0.17
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
257
0.89
0.17
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
66
0.76
0.17
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
66
0.76
0.17
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
68
0.73
0.17
1.4
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
53
495
1.07
0.17
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
101
1.19
0.16
1.1
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
151
0.86
0.16
1.2
1.2
—
1.4
—
0
11
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
149
1.14
0.15
1.6
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
39
420
0.93
0.15
2.8
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
366
0.93
0.13
1.6
1.3
miu/ml
339.0
224.3
—
8
180
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
138
0.87
0.13
1.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
26
241
1.08
0.10
1.6
1.7
—
223.6
—
0
11
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
177
0.90
0.10
1.8
1.3
u/ml
91.7
103.9
—
9
40
(3051651) Icteric interference index of Serum or Plasma
5
44
1.14
0.10
4.8
3.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
97
1.14
0.09
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
126
1.11
0.09
1.4
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
30
282
1.07
0.09
1.5
2.1
s
20.2
21.1
0.61
20
246
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
107
1.12
0.08
1.1
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
146
1.10
0.08
1.6
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
195
1.08
0.08
1.5
2.0
iu/l
2.5
5.3
—
7
77
(3022145) Colonoscopy Study observation
82
844
0.97
0.08
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.6
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
89
1.12
0.07
1.9
1.4
nmol/l
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
173
1751
0.99
0.05
4.0
3.7
%
92.5
95.1
0.85
161
1704
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
101
1.09
0.04
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
121
1.08
0.03
1.9
2.9
—
—
—
0
0
(4306422)
15
141
1.06
0.03
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
50
511
0.98
0.03
1.4
1.4
iu/l
19.4
24.3
0.75
38
434
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
188
0.96
0.02
1.7
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
126
0.95
0.00
3.1
3.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
47
468
1.00
0.00
1.6
1.8
g/l
1.4
1.3
0.03
41
437
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
147
1.02
0.00
1.1
1.1
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
3.7
—
0
9
(3045142) Bone marrow Pathology biopsy report
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44790049)
7
69
1.01
0.00
1.6
1.9
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.6
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
14.2
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
59
1.02
0.00
3.0
1.7
—
—
—
0
0
(44806118)
7
69
1.01
0.00
1.6
1.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
100.8
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
110
1.00
0.00
1.0
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
56
0.89
0.00
1.2
1.4
e6/l
19772.0
11615.3
—
5
41
(3039162) Centromere protein B Ab [Units/volume] in Serum
9
97
0.93
0.00
1.1
1.3
—
30.1
—
0
5
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
11.3
—
0.5
—
0
8
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
2.6
—
10.1
—
0
7
(4062490)
8
81
0.99
0.00
1.1
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
341.3
—
0
6
(3051611) Lipemic interference index of Serum or Plasma
5
57
0.88
0.00
5.4
3.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
64.0
—
0
5
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
68
0.88
0.00
1.2
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
36.5
—
0
5
(44790047)
7
69
1.01
0.00
1.6
1.9
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
57
0.88
0.00
1.6
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
73
0.96
0.00
1.3
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
14.4
—
0
7
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
53
0.94
0.00
2.8
4.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
6
0.00
0.00
0.0
3.5
—
396.8
—
0
6
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
86
0.93
0.00
1.1
1.1
—
—
—
0
0
(44790048)
7
69
1.01
0.00
1.6
1.9
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_SCHIZOTYP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_SCHIZOTYP | 3.105 [2.62, 3.68] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.117 |
During the follow-up period (1.1.1998 — 31.12.2019), 409 out of 2711 females with F5_SCHIZOTYP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_SCHIZOTYP | 3.259 [2.88, 3.69] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 565 out of 3557 males with F5_SCHIZOTYP died.
Mortality risk
Mortality risk for people of age
years, who have F5_SCHIZOTYP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.202% | 0.624% |
| 5 | 1.49% | 3.678% |
| 10 | 3.838% | 9.119% |
| 15 | 7.383% | 16.73% |
| 20 | 12.971% | 26.481% |
Relationships between endpoints
↥Index endpoint: F5_SCHIZOTYP – Schizotypal disorder
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data